| |
|
|
|
Kintara Therapeutics Inc.  
|
|
1.5 0.11 (0.08%) |
01-15 16:00 |
|
Open: |
1.38 |
Pre close: |
1.39 |
Target:
|
1.87 
|
|
High: |
1.59 |
Low: |
1.38 |
Resistance:
|
1.60
1.87
|
|
Volume: |
1,133,849 |
Market Cap: |
37M |
Support:
|
1.39
1.26
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.43
|
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
1.37 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
1.41 |
Stochastic Oscillator |
%K(14,3):
|
60.24 |
|
MA(250): |
0.00 |
%D(3): |
63.70  |
|
Average Volume(K) |
3-Month: |
39387
|
52-Week |
High:
|
1.95 |
|
10-Days: |
50682 |
Low: |
0.38 |
|
RSI |
RSI(14):
|
61.56 |
Change(%): |
134.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-196.1 |
Shares Out. (M) |
24.66 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-37.3 |
Shares Float (M) |
20.47 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
34.43 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.21 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
158 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.77 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.03 |
P/CF |
-3.79 |
|
|
|
|
|
|
